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Purpose: Kashin-Beck disease is an osteoarthropathy associ- 
ated with severe selenium (Se) deficiency in China. No studies 
have evaluated the role of Se in CA in Western populations. We 
report the first study of Se biomarkers in both knee and hip CA in 
blacks and whites in North Carolina. 
Methods: 940 participants in the Johnston County Osteoarthri- 
tis Project (mean age 59.8 (10.4) years; 40% black; 33% male) 
submitted toenails for Se assessment by Instrumental Neutron 
Activation Analysis; laboratory personnel were blinded to all de- 
mographic and outcome data. Radiographic knee and hip CA 
was defined as Kellgren-Lawrence grade 2-4, using fixed flex- 
ion PA knee and AP supine pelvis films, respectively. Laterality 
of knee CA was defined as none, unilateral, bilateral; and sever- 
ity as none, mild, moderate/severe. The combination of knee and 
hip CA was defined as none, knee or hip CA, both knee + hip 
CA, and the number of joints with CA was defined as 0, 1,2, 3/4. 
General linear models were used to assess associations between 
CA variables and logarithmically-transformed Se levels (InSe), 
adjusting for age, gender, race, and body mass index. Multiple 
logistic regression was used to examine increases in Se levels 
(0.1 ppm) and in tertiles of Se, adjusting for the same variables. 
Similar proportional odds models were examined for the combi- 
nation of knee and hip CA and for number of joints with CA. 
Results: Median Se levels were 0.75 ppm (geometric mean (SD) 
0.76(0.12)). Adjusted least squares means for Se were lower in 
blacks than whites, (0.71 vs 0.78, p < 0.0001), men than women 
(0.73 vs 0.76, p < 0.0001), and those with any knee CA, bilateral 
knee CA, and severe knee CA (p _< 0.05); knee and hip CA, and 
3 or 4 joints with CA (p< 0.07), compared with those with nor- 
mal x-rays. For every increase of 0.1 ppm Se, the odds of knee 
CA, bilateral knee CA, and severe knee CA were decreased by 
about 15 - 20%: adjusted OR (95% CI) were 0.85 (0.72-1.00) for 
knee CA; 0.79 (0.65-0.96) for bilateral knee CA; and 0.82 (0.69- 
0.98) for severe knee CA, and by 10% for those with knee + hip 
CA: 0.89 (0.78, 1.01) and for those with 3 or 4 CA joints: 0.90 
(0.79, 1.02). Compared with those in the lowest tertile, for those 
in the highest tertile the odds of knee CA were 0.62 (0.37-1.02); 
for bilateral knee CA 0.54 (0.31-0.97); and severe knee CA 0.56 
(0.34-0.94). Cumulative odds were 0.65 (0.45, 0.96) for both knee 
and hip CA, and 0.66 (0.46, 0.96) for increasing number of knees 
and hips with CA. 
Conclusions: Low toenail Se levels are associated with in- 
creased odds of radiographic knee CA, bilateral and severe knee 
CA, the combination of knee and hip CA, and increasing number 
of joints with CA. Low Se is a new potentially modifiable risk fac- 
tor for CA. Future studies should examine whether treatment with 
Se supplements can reduce the development and progression of 
CA. 
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Study Aims: We conducted a case-control study nested within 
a longitudinal study of normative aging to test the hypothesis 
that changes in serum proteins accompany knee and hand os- 
teoarthritis (CA), and can be detected years before the CA be- 
comes radiographically evident. 
Methods: A case-control study nested within a longitudinal nor- 
mative aging study was conducted (Fig. 1). Participants without 
significant CA on initial knee and hand x-rays obtained between 
1984 and 1991 were classified as CA cases (n=19) or no CA 
controls (n=66) by follow-up x-rays performed between 1995 and 
1998, and matched by age, sex and body mass index. Serum 
samples obtained at the time of classification and 10 years be- 
fore were applied to microarray platforms that assayed 160 pro- 
teins together with internal control standards. Proteins with mean 
signal intensities 4-fold higher than control blanks were normal- 
ized by Z-scores and compared between cases and controls us- 
ing multivariate techniques. 
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Results: Sixteen proteins implicated in matrix degradation, 
cellular activation and inflammation were associated with CA 
at both time points (Fig. 2). Four of these proteins (ma- 
trix metalloproteinase-7, interleukin-15, plasminogen activating 
inhibitor-1 and soluble vascular adhesion protein-1 were already 
differentially expressed in samples obtained 10 years earlier. Six 
additional proteins were only associated with subsequent CA de- 
velopment and not with established CA. Results of the multivari- 
ate analyses suggest that protein clusters may improve classifi- 
cation accuracy distinguishing cases from controls beyond that 
achieved using single proteins. 
Conclusions: We conclude that osteoarthritis is associated with 
changes in serum proteins implicated in matrix degradation, cel- 
lular activation and inflammation years before radiographic de- 
tection, and that the pattern of proteins predictive of future CA is 
partially different from the patterns associated with prevalent CA. 
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These individual and clusters of proteins may prove to be early 
biomarkers of osteoarthritis, and potentially guide future develop- 
ment of therapeutic agents. 
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Background: Various models have been proposed for the pre- 
clinical study of generalised, non-inflammatory joint disease. The 
Hartley guinea pig is a spontaneous OA model and recently 
ovariectomy-induced, relatively mild cartilage erosions were de- 
scribed in the rat (Hoegh-Andersen et al., Arthritis Res Ther 2004; 
6:R169-R180). Biochemical markers, including fragments of type 
II collagen, have been applied for monitoring disease progres- 
sion in these preclinical models. The urinary concentration of C- 
telopeptides of type II collagen (CTX-II) is correlated to extent of 
cartilage erosion, however, collection of urine is inconvenient in 
animals, and therefore appropriate serum tests are needed to fa- 
cilitate preclinical research. 
Aim of Study: To compare the occurrence of type II collagen 
degradation in articular cartilage with the presence of collagen 
fragments in urine and serum in a novel model of ovariectomy- 
induced accelerated cartilage degradation. 
Methods: Six months old female Sprague Dawley rats were ei- 
ther ovariectomised (11 animals) or sham operated (11 animals), 
and subsequently euthanised at day 7 (4 animals from each 
group), day 14 (4 animals from each group), and day 28 (3 ani- 
mals from each group). Blood and urine samples were collected 
at baseline and weeks 2 and 4 after operation. Four non-operated 
animals served as additional controls. Immunohistological detec- 
tion of C-telopeptide fragments were performed in joint sections 
from all animals using monoclonal antibody F46 recognising the 
neo-epitope EKGPDP having a free C-terminal proline. In addi- 
tion, CTX-II was quantitatively assessed by immunoassay in the 
urine and serum specimens. 
Results: The presence of telopeptide fragments of type II colla- 
gen was observed in growth plate in all rats. However, two and 
four weeks after ovariectomy, collagen type II neo-epitopes could 
in addition be detected in the superficial zone of articular carti- 
lage. This was absent in sham operated and control animals. Both 
urine and serum CTX II demonstrated an ovariectomy-induced el- 
evation of 180-190% (both p<0.001 ) two weeks after operation. 
Conclusion: The simultaneous presence of type II collagen neo- 
epitopes, i.e. EKGPDP-containing fragments, in sections of ar- 
ticular cartilage as well as in serum and urine suggest that the 
increase in blood and urine levels of CTX-II originates from an 
increased destruction of articular cartilage in this model of accel- 
erated cartilage degradation. 
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Age-related changes in articular cartilage are likely to play a 
role in the etiology of OA. One of the major changes in the ex- 
tracellular matrix of cartilage is the age-related accumulation of 
advanced glycation end products (AGEs). Pentosidine, an AGE 
crosslink, is one of the few characterized AGEs and is consid- 
ered an adequate marker for the many AGEs that are formed in 
vivo. We used data from a longitudinal observation study to de- 
termine if pentosidine could serve as a marker to predict cartilage 
loss. 
Materials and Methods: We conducted an prospective analysis 
of data from the Boston Osteoarthritis of the Knee Study (BOKS); 
a completed natural history study of knee osteoarthritis. All sub- 
jects in the study met ACR criteria for knee OA. Knee MR im- 
ages were scored for cartilage in 14 plates of the knee using 
the WORMS semi-quantitative grading scheme. Within the BOKS 
population 127 subjects had both baseline pentosidine and longi- 
tudinal MRI measurements (MRI's performed at baseline and 30 
months later). Urinary pentosidine was assayed and normalized 
to creatinine to account for differences in urine concentrations. 
We analyzed the data using 3 different methods to assess if base- 
line measures of pentosidine predicted subsequent cartilage loss 
on MRI. These were: 1) Analysis 1- logistic regression with the 
outcome cartilage loss in any plate; 2) Analysis 2- proportional 
odds model where the outcome was defined as 0= no cartilage 
loss, 1=cartilage loss in 1 plate, 2= cartilage loss in 2 plates, and 
3= cartilage loss in at least 3 plates; and 3) Analysis 3- Poisson 
regression with the outcome the number of plates with cartilage 
loss. All analyses were adjusted for age, sex and BMI. 
Results: At baseline the mean (SD) age was 67 (9) years and 
60% were male. The results for the three analytic steps are as fol- 
lows: Analysis 1 - the odds ratio for cartilage loss is 0.996 (95%CI 
0.92- 1.07) with 1 unit increase in pentosidine. Analysis 2- the 
odds ratio for more cartilage loss is 0.993 (95%CI 0.93, 1.07) with 
1 unit increase in pentosidine. Analysis 3- The relative number of 
plates with cartilage loss decreased by 0.2% (95%CI -3% to 3%) 
with a 1 unit increase in pentosidine. 
Conclusion: Urine pentosidine does not predict knee cartilage 
loss. Previous studies have suggested that local content within 
cartilage of AGE's is elevated in persons at high risk for progres- 
sion. Our data suggest that these changes are not measurable 
systemically. Alternatively, urinary pentosidine levels reflect car- 
tilage degradation in all joints (thus whole body cartilage break- 
down) and may therefore not relate to OA severity in a single knee 
joint. 
